EARLY BREAST CANCER
Clinical trials for EARLY BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new EARLY BREAST CANCER trials appear
Sign up with your email to follow new studies for EARLY BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to keep breast cancer at bay in High-Risk patients
Disease control Recruiting nowThis study tests whether adding ribociclib to standard hormone therapy can help prevent breast cancer from coming back in people with HR+ HER2- early breast cancer. About 1,400 adults with stage II or III breast cancer will receive the combination after surgery. The goal is to se…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
MRI-Guided breast cancer trial aims to spare patients from toxic chemo
Disease control Recruiting nowThis study tests whether an MRI scan can identify triple-negative breast cancer patients who respond well to initial chemotherapy and immunotherapy, allowing them to skip a second, more toxic chemo phase. About 54 participants will receive four cycles of paclitaxel, carboplatin, …
Matched conditions: EARLY BREAST CANCER
Phase: PHASE2 • Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
Scientists map fat storage in breast tumors to unlock new clues
Knowledge-focused Recruiting nowThis study collects tumor samples from 1,050 people with early or metastatic breast cancer to analyze fat storage and protein patterns inside cancer cells. Researchers want to see how these features differ across breast cancer subtypes. No treatment is given—the goal is to gather…
Matched conditions: EARLY BREAST CANCER
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC